Anti-Helicobacter pyloritreatment can effectively improve the clinical remission rates of irritable bowel syndrome: a controlled clinical trial meta-analysis
- Resource Type
- Article
- Authors
- Xiong, Yan; Liu, Lulu; Zhou, Xuchun; Wen, Youfei; Wang, Ruonan
- Source
- Clinics; January 2020, Vol. 75 Issue: 1
- Subject
- Language
- ISSN
- 18075932; 19805322
Here we used a meta-analysis of several clinical trials to determine whether anti-Helicobacter pyloritherapy has any positive effect on IBS patients. Here we compared the effective clinical remission rates between IBS patients treated with anti-H. pyloritherapy and those who were not. This data would provide more clinical evidence regarding the efficacy of novel treatments and intervention points for IBS patients.